When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data
Top Cited Papers
- 13 January 2010
- journal article
- Published by Walter de Gruyter GmbH in The International Journal of Biostatistics
- Vol. 6 (2) , Article 18
- https://doi.org/10.2202/1557-4679.1212
Abstract
Dynamic treatment regimes are the type of regime most commonly used in clinical practice. For example, physicians may initiate combined antiretroviral therapy the first time an individual's recorded CD4 cell count drops below either 500 cells/mm3 or 350 cells/mm3. This paper describes an approach for using observational data to emulate randomized clinical trials that compare dynamic regimes of the form “initiate treatment within a certain time period of some time-varying covariate first crossing a particular threshold." We applied this method to data from the French Hospital database on HIV (FHDH-ANRS CO4), an observational study of HIV-infected patients, in order to compare dynamic regimes of the form "initiate treatment within m months after the recorded CD4 cell count first drops below x cells/mm3" where x takes values from 200 to 500 in increments of 10 and m takes values 0 or 3. We describe the method in the context of this example and discuss some complications that arise in emulating a randomized experiment using observational data.Keywords
This publication has 18 references indexed in Scilit:
- Estimation and extrapolation of optimal treatment and testing strategiesStatistics in Medicine, 2008
- Does obesity shorten life? The importance of well-defined interventions to answer causal questionsInternational Journal of Obesity, 2008
- Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapyAIDS, 2008
- Causal Effect Models for Realistic Individualized Treatment and Intention to Treat RulesThe International Journal of Biostatistics, 2007
- Comparison of Dynamic Treatment Regimes via Inverse Probability WeightingBasic & Clinical Pharmacology & Toxicology, 2006
- Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort studyThe Lancet, 2005
- Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapiesStatistics in Medicine, 2004
- Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural ModelsAmerican Journal of Epidemiology, 2003
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997